Abiopharma

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology

DexCom, Inc. - Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress

Savara Inc. - Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*

Amneal Pharmaceuticals, Inc. - Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

Johnson & Johnson - Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile

Teva Pharmaceutical Industries Ltd. - Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with‘Honestly HD’

INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of Agilon Health, Inc. (NYSE: AGL) and Encourages Long-Term AGL Stockholders to Contact the Firm - AGL

INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ: DXCM) and Encourages Long-Term Investors to Contact the Firm

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile

Volition Announces Data to Support Use of Nu.Q® NETs in New Indication